MOBILE COMMUNICATION APPARATUS AND ANTENNA STRUCTURE
    1.
    发明申请
    MOBILE COMMUNICATION APPARATUS AND ANTENNA STRUCTURE 审中-公开
    移动通信装置和天线结构

    公开(公告)号:US20100255893A1

    公开(公告)日:2010-10-07

    申请号:US12693616

    申请日:2010-01-26

    CPC classification number: H01Q1/243 H01Q21/28 H04W88/02

    Abstract: A mobile communication apparatus configured to be provided with an extra antenna has a printed board provided with an antenna feed point, an antenna having a spring-like contact and provided on the printed board, and a housing constituted by a first case and a second case fixed into each other. The printed board and the antenna are arranged between and pressed by the first case and the second case. The antenna feed point and the spring-like contact are in contact with and electrically connected to each other by means of elastic force of the spring-like contact caused upon the first case and the second case being fixed into each other. The housing has a space for containing the extra antenna such that the extra antenna is electrically connected to the antenna feed point by means of the elastic force.

    Abstract translation: 配置成设置有额外天线的移动通信装置具有设置有天线馈电点的印刷电路板,具有弹簧状接触并设置在印刷电路板上的天线以及由第一壳体和第二壳体构成的壳体 相互固定 印刷电路板和天线布置在第一壳体和第二壳体之间并被第一壳体和第二壳体按压之间。 天线馈电点和弹簧状触点通过在第一壳体上引起的弹簧状接触的弹力彼此接触并彼此电连接,并且第二壳体彼此固定。 壳体具有用于容纳额外天线的空间,使得额外的天线通过弹性力电连接到天线馈电点。

    Aminoalcohol derivatives
    3.
    发明授权
    Aminoalcohol derivatives 失效
    氨基醇衍生物

    公开(公告)号:US07417060B2

    公开(公告)日:2008-08-26

    申请号:US11016886

    申请日:2004-12-21

    Abstract: The present invention relates to a compound formula[I]: wherein X is bond, —CH2—, —O— or —NH—, R1 and R12 are each independently hydrogen, halogen, lower alkyl, etc., R2 is hydrogen or optionally substituted lower alkyl, R3 is hydrogen or an amino protective group, R4, R5 and R6 are each independently hydrogen or optionally substituted lower alkyl, R7 is -Z-R13, in which Z is bond, etc., and R13 is carboxy, lower alkoxycarbonyl, (lower alkylsulfonyl)carbamoyl or lower alkanoylsulfamoyl, R8 is —Y—R9, in which Y is bond, —CH2—, —O—, —S—, etc., and R9 is hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R11 is hydrogen, lower alkyl, lower alkoxy, etc., or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

    Abstract translation: 本发明涉及化合物式[I]:其中X是键,-CH 2 - , - O-或-NH-,R 1和R 2 > 12个各自独立地为氢,卤素,低级烷基等,R 2为氢或任选取代的低级烷基,R 3为氢或氨基 保护基,R 4,R 5和R 6各自独立地为氢或任选取代的低级烷基,R 7 O 其中Z为键,等等,R 13为羧基,低级烷氧基羰基,(低级烷基磺酰基)氨基甲酰基或低级烷酰基氨磺酰基,R 0为 其中Y为键,-CH 2 - , - O - , - S-等,其中R为 - 低级烷基,环(低级)烷基等,R 11是氢,低级烷基,低级烷氧基等,或其盐。 本发明的化合物[I]及其药学上可接受的盐可用于预防和/或治疗呼吸窘迫症或尿失禁。

    Aminoalcohol Derivatives
    5.
    发明申请
    Aminoalcohol Derivatives 失效
    氨基醇衍生物

    公开(公告)号:US20080039506A1

    公开(公告)日:2008-02-14

    申请号:US11547847

    申请日:2005-09-20

    Abstract: The present invention relates to a compound of the formula [I]: wherein (a), in which —Y—, R4, R5 and R6 are4 R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy, etc., R2 is hydrogen, lower alkyl or hydroxy(lower)alkyl, R3 is hydrogen or an amino protective group, 20R7 is hydrogen, lower alkyl, cyclo(lower)alkyl, lower R9 alkenyl, -Z-R9 or (b), in which -Z- is -0-, —S—, R9—SO— or —SO2—, and each R9 is independently hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R8 is -D-E-R , in which -D- is —CONHSO2— or —S02NHCO—, E is bond or lower alkylene, and R10 is halogen, cyano, carboxy, etc., or a prodrug thereof or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of ulcer, overactive bladder, and the like.

    Abstract translation: 本发明涉及式[I]化合物:其中(a),其中-Y-,R 4,R 5和R 6 每一个如说明书中所定义的,其中R 1是氢,卤素,低级烷基,羟基 等等,R 2是氢,低级烷基或羟基(低级)烷基,R 3是氢或氨基保护基,R 20,R 20, 其中-Z-是-O - , - S - , - S(O) - , - (R) 9个-SO-或-SO 2 - ,每个R 9独立地是氢,低级烷基,环(低级)烷基等,R 其中D是-CONHSO 2 - 或-SO 2 NHCO-,其中D是 - E是键或低级亚烷基,R 10是卤素,氰基,羧基等,或其前药或其盐。 本发明的化合物[I]及其药学上可接受的盐可用于溃疡,膀胱过度活动症等的预防和/或治疗性治疗。

    Food and drink managing device in circulation type carrying path
    6.
    发明授权
    Food and drink managing device in circulation type carrying path 有权
    食品饮料管理装置在循环式携带路径中

    公开(公告)号:US07243758B2

    公开(公告)日:2007-07-17

    申请号:US10758788

    申请日:2004-01-16

    CPC classification number: A47F10/06

    Abstract: A food and drink managing device with a circulation type path allows standardizing while adding food and drink onto the carrying path, simplifying management, holding down cost, and achieving precise identification information reading. The food and drink managing device with a circulation type carrying path has containers with identification information, an identification information reading means provided near said path, a sign part circularly moving as linked with said circulating carrying path, passage detection means for detecting passage of said sign parts, a registering means which recognizes an interval between passing sign parts as one zone, and registers the identification information of the containers read by said reading means, as foods and drinks being supplied, in relation to a zone in which the containers exist, and a container throwing-in prohibited area of a given length provided in the upstream side of the circulating carrying path from a position of the reading means.

    Abstract translation: 具有循环型路径的食品饮料管理装置允许在携带路径上添加食物和饮料进行标准化,简化管理,降低成本,并实现精确的识别信息阅读。 具有循环型运送路径的饮食管理装置具有容器,具有识别信息的容器,在所述路径附近设置的识别信息读取装置,与所述循环运送路径相连接的循环移动的标志部,用于检测所述符号的通过的通过检测单元 识别作为一个区域的通过标志部分之间的间隔的登记装置,并且将由所述读取装置读取的容器的识别信息作为提供的食品和饮料相对于容器存在的区域进行登记,以及 从读取装置的位置设置在循环运送路径的上游侧的给定长度的容器投入禁止区域。

    Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors
    10.
    发明授权
    Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors 失效
    脒基取代的四氢苯并噻吩或呋喃衍生物及其用作尿激酶抑制剂

    公开(公告)号:US06274619B1

    公开(公告)日:2001-08-14

    申请号:US09584136

    申请日:2000-05-31

    Abstract: A compound of the formula: in which R1 is hydrogen, optionally substituted lower alkylcarbamoyl(lower)alkylidene, lower alkylidene, lower alkyl, optionally substituted ar(lower)alkyl, cyclo(lower)alkyl(lower)alkyl, protected carboxy(lower)alkyl, carboxy(lower)alkyl, hydroxy(lower)alkyl, optionally substituted lower alkylcarbamoyl(lower)alkyl, lower alkylthio(lower)alkyl, carboxy(lower)alkanoyl, protected carboxy(lower)alkanoyl, aroyl, lower alkanoyl, or optionally substituted arylcarbamoyl(lower)alkyl, R2 is hydrogen, carboxy, protected carboxy, formyl or N-(lower)alkyl-N-(lower)alkoxycarbamoyl, R3 is hydrogen or amidino-protective group, A is lower alkylene or carbonyl, X is Y is lower alkylene, —S— or —SO2—, Z is —S— or —O—, and the line: is a single bond or a double bond, or pharmaceutically acceptable salts thereof, which is useful as a medicament.

    Abstract translation: 下式化合物:其中R 1为氢,任选取代的低级烷基氨基甲酰基(低级)亚烷基,低级亚烷基,低级烷基,任选取代的芳(低级)烷基,环(低级)烷基(低级)烷基,被保护的羧基 ,羧基(低级)烷基,羟基(低级)烷基,任选取代的低级烷基氨基甲酰基(低级)烷基,低级烷硫基(低级)烷基,羧基(低级)烷酰基,受保护羧基(低级)烷酰基,芳酰基,低级烷酰基或任选取代 芳基氨基甲酰基(低级)烷基,R2是氢,羧基,保护的羧基,甲酰基或N-(低级)烷基-N-(低级)烷氧基氨基甲酰基,R3是氢或脒基保护基,A是低级亚烷基或羰基,X是Y 低级亚烷基,-S-或-SO 2 - ,Z是-S-或-O-,并且行:是 单键或双键,或其药学上可接受的盐,其可用作药物。

Patent Agency Ranking